Skip to Content

XR 150 (Quetiapine Fumarate Extended-Release 150 mg)

Pill with imprint XR 150 is White, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 150 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Quetiapine is used in the treatment of bipolar disorder; generalized anxiety disorder; schizoaffective disorder; depression; schizophrenia (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for XR 150

Quetiapine Fumarate Extended-Release

Imprint:
XR 150
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC):
00310-8281

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide